Literature DB >> 10498878

Acute promyelocytic leukemia: from treatment to genetics and back.

S C Kogan1, J M Bishop.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498878     DOI: 10.1038/sj.onc.1202996

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  5 in total

1.  Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.

Authors:  Kim De Keersmaecker
Journal:  Haematologica       Date:  2012-06       Impact factor: 9.941

2.  Hijacking T cell differentiation: new insights in TLX function in T-ALL.

Authors:  Bryan King; Panagiotis Ntziachristos; Iannis Aifantis
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

Review 3.  How animal models of leukaemias have already benefited patients.

Authors:  Julien Ablain; Rihab Nasr; Jun Zhu; Ali Bazarbachi; Valérie Lallemand-Breittenbach; Hugues de Thé
Journal:  Mol Oncol       Date:  2013-02-11       Impact factor: 6.603

4.  Retinoic acid receptor and retinoid X receptor in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.

Authors:  N Ariga; T Moriya; T Suzuki; M Kimura; N Ohuchi; H Sasano
Journal:  Jpn J Cancer Res       Date:  2000-11

5.  Cinobufagin induces acute promyelocytic leukaemia cell apoptosis and PML-RARA degradation in a caspase-dependent manner by inhibiting the β-catenin signalling pathway.

Authors:  Yaoyao Bian; Mei Xue; Xinlong Guo; Wenjuan Jiang; Ye Zhao; Zhaofeng Zhang; Xian Wang; Yongkang Hu; Qi Zhang; Wenliang Dun; Liang Zhang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.